# An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).

> **NCT00492323** · PHASE2 · COMPLETED · sponsor: **SK Life Science, Inc.** · enrollment: 91 (actual)

## Conditions studied

- Postherpetic Neuralgia
- Neuralgia
- Herpes Zoster

## Interventions

- **DRUG:** placebo
- **DRUG:** carisbamate

## Key facts

- **NCT ID:** NCT00492323
- **Lead sponsor:** SK Life Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492323, "An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN).". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00492323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*